metricas
covid
Enfermedades Infecciosas y Microbiología Clínica (English Edition) Answer to diagnostic limitations in tuberculous meningitis
Journal Information
Vol. 42. Issue 7.
Pages 396 (August - September 2024)
Letter to the Editor
Full text access
Answer to diagnostic limitations in tuberculous meningitis
Respuesta a la carta sobre las limitaciones del diagnóstico de meningitis tuberculosa
Visits
378
Lluïsa Guillema,
Corresponding author
lui.gui.ti@gmail.com

Corresponding author.
, Miguel Santínb
a Departamento de Enfermedades Infecciosas, Hospital Universitari de Bellvitge-Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain
b Unidad de Tuberculosis, Departamento de Enfermedades Infecciosas, Hospital Universitari de Bellvitge-Institut d’Investigació Biomèdica de Bellvitge (IDIBELL); Departamento de Ciencias Clínicas, Universitat de Barcelona, Hospitalet de Llobregat, Barcelona, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text
Dear Editor,

Given the limitations of the microbiological tests, tuberculous meningitis is a diagnostic challenge. The sensitivity of the culture is very low (20%), and although molecular techniques have been perfected in recent years, their sensitivity in cerebrospinal fluid is 60%–70%.1 Due to these limitations, in our study2 we used the criteria defined in a consensus, created precisely with the objective of facilitating definition and comparison in clinical research.3 Focusing only on microbiologically confirmed cases would have incorporated a very significant bias, excluding many of the cases and making the cohort incomparable with clinical practice, in addition to preventing comparison between periods, since molecular techniques were incorporated and developed over the course of the study period. In any event, we made the comparison between microbiologically confirmed cases and those which were not, and we found no significant differences in either mortality rates (13/60 [21.7%] vs 10/75 [13.3%], P = .20) or sequelae (14/39 [35.9%] vs 12/53 [22.6%], P = .163).

References
[1]
J. Huynh, J. Donovan, N.H. Phu, H.D.T. Nghia, N.T.T. Thuong, G.E. Thwaites.
Tuberculous meningitis: progress and remaining questions.
Lancet Neurol., 21 (2022), pp. 450-464
[2]
L. Guillem, J. Espinosa, J. Laporte-Amargos, A. Sánchez, M.D. Grijota, M. Santin.
Mortality and sequelae of tuberculous meningitis in a high-resource setting: a cohort study, 1990-2017.
Enferm Infecc Microbiol Clin (Engl Ed)., 42 (2024), pp. 124-129
[3]
S. Marais, G. Thwaites, J.F. Schoeman, M.E. Török, U.K. Misra, K. Prasad, et al.
Tuberculous meningitis: a uniform case definition for use in clinical research.
Lancet Infect Dis., 10 (2010), pp. 803-812
Copyright © 2024. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Download PDF
Article options
Tools